ACR Convergence 2025| Video: Rheum for Everyone, Episode 26—Ableism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: pain

Workforce Solutions

Mithu Maheswaranathan, MD  |  November 14, 2025

Three experts discussed novel and practical strategies and resources that rheumatology clinics can use to improve the referral process, screening times and patients access to care.

Filed under:ACR ConvergenceMeeting ReportsPractice Support Tagged with:ACR Convergence 2025eConsultPractice ManagementPrimary Care PhysiciansreferralsWorkforce

Complementary Medicine Meets Rheumatology: New Ways to Reduce Inflammation

Ruth Jessen Hickman, MD  |  November 14, 2025

At this ACR Convergence 2025 session, the speaker highlighted ways complementary and alternative medicine can be used alongside traditional medical treatments.

Filed under:ACR ConvergenceMeeting ReportsRheumatoid Arthritis Tagged with:ACR Convergence 2025ACR Convergence 2025 - RAComplementary and Alternative TherapiesDietstress managementsupplements

ARP Year in Review: Updates in Advanced Practice, Epidemiology & Rehabilitation

Catherine Kolonko   |  November 12, 2025

Three experts discussed recent notable research of interest to rheumatology professionals across a range of topics.

Filed under:ACR ConvergenceConditionsMeeting ReportsOsteoarthritis and Bone Disorders Tagged with:ACR Convergence 2025Association of Rheumatology Professionals (ARP)OsteoarthritisResearch

Secrets & Pearls of Rheumatology at ACR Convergence 2025

Mithu Maheswaranathan, MD  |  November 12, 2025

Two clinical diagnosticians presented their pearls of wisdom for clinical rheumatologists to take forward when managing patients from the clinics to the hospital wards.

Filed under:ACR ConvergenceMeeting ReportsMyositisOther Rheumatic ConditionsSjögren’s DiseaseSystemic Lupus ErythematosusVasculitis Tagged with:ACR Convergence 2025ACR Convergence 2025 - LNconnective tissue diseaseLupusLupus nephritismyositisRaynaud’s phenomenonRheumatic DiseaseSjögren's Diseasesystemic lupus erythematosus (SLE)

3 AC&R Study Summaries: RA & Frailty, Hydroxychloroquine Can Protect Kidneys in Lupus Nephritis, & PT for Knee OA

Arthritis Care & Research  |  November 11, 2025

Research on PT for knee OA, HCQ’s protective role in lupus nephritis & the link between RA disease activity & frailty.

Filed under:ConditionsGuidanceOsteoarthritis and Bone DisordersResearch RheumRheumatoid ArthritisSystemic Lupus Erythematosus Tagged with:AC&RArthritis Care & ResearchfrailtyHydroxychloroquine (HCQ)kidney diseaseknee osteoarthritisLupus nephritisPhysical TherapyReferral

Why Target B Cells in SSc-ILD?

Katie Robinson  |  November 11, 2025

In a recent Arthritis & Rheumatology review article, three experts discuss the use of immunosuppressants to target B cells in a patient with systemic sclerosis-interstitial lung disease.

Filed under:Biologics/DMARDsConditionsDrug UpdatesResearch RheumSystemic Sclerosis Tagged with:B cellsCAR-T cell therapycase reportimmunosuppressioninterstitial lung disease (ILD)mycophenolate mofetilrituximabSSc-ILDSystemic sclerosis

Rheuminations: Address Ableism, Improve Care for All Patients

Bharat Kumar, MD, MME, FACP, FAAAAI, RhMSUS  |  November 10, 2025

Ableism—discrimination against those with disabilities—distorts diagnostic reasoning & erodes patient trust. How can rheumatologists address this bias?

Filed under:EthicsOpinionRheuminations Tagged with:ableismAccess to carecommunicationdisabilityhealth disparitiespatient-centered care

New Rheumatoid Arthritis Risk Stratification Criteria Released

Ruth Jessen Hickman, MD  |  November 10, 2025

New EULAR/ACR criteria help stratify RA risk in patients with arthralgia. Learn how these criteria guide earlier interventions & improve trial rigor.

Filed under:Clinical Criteria/GuidelinesConditionsEULAR/OtherGuidanceResearch RheumRheumatoid Arthritis Tagged with:ACPAarthralgiasC-reactive proteinearly RAPreclinical Rheumatoid ArthritisRA Resource CenterRheumatoid FactorRisk Factorsrisk stratification

Collaboration Is Key to Oral Health in Scleroderma & Sjögren’s Disease

Catherine Kolonko  |  November 7, 2025

At this ACR Convergence 2025 session, experts discussed the oral manifestations of scleroderma & Sjögren’s disease & the importance of dentists & rheumatologists working together.

Filed under:ACR ConvergenceConditionsMeeting ReportsSjögren’s Disease Tagged with:ACR Convergence 2025oral manifestationsSclerodermaSjogren'sSjögren's Disease

Differentiating POTS from Other Conditions

Mary Beth Nierengarten  |  November 6, 2025

At a ACR Convergence 2025 session, two experts discussed POTS, the importance of considering dysautonomia when making a differential diagnosis & an interdisciplinary approach to treatment.

Filed under:ACR ConvergenceMeeting Reports Tagged with:ACR Convergence 2025DysautonomiaPOTS

  • « Previous Page
  • 1
  • …
  • 24
  • 25
  • 26
  • 27
  • 28
  • …
  • 249
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences